clinical pharmacy in nephrology acute renal failure

33

Upload: stanley-taylor

Post on 29-Jan-2016

227 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE
Page 2: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

CLINICAL PHARMACY IN NEPHROLOGY

ACUTE RENAL FAILURE

Page 3: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Background

• Common in Hospitalized patients

• Associated with high Morbidity and Mortality

• Often Multifactorial

• Identifiable risk factors.

Page 4: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE
Page 5: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE
Page 6: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Acute Renal Failure

• Sudden decrease in function (hours-days)

• Often multifactorial

• Pre-renal and intrinsic renal causes 70%

• oliguric UOP < 400 ml

• Non-oliguric (up to 65%)

• Associated with high mortality and morbidity

Page 7: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE
Page 8: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Acute Renal Failure Diagnosis

• Laboratory Evaluation:– Scr, More reliable marker of GFR

• Falsely elevated with Septra, Cimetidine• small change reflects large change in GFR

– BUN, generally follows Scr increase• Elevation may be independent of GFR

– Steroids, GIB, Catabolic state, hypovolemia

– BUN/Cr helpful in classifying cause of ARF• ratio> 20:1 suggests prerenal cause• ratio 10-15:1 suggests intrinsic renal cause

Page 9: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Acute Renal FailureDiagnosis (cont’d)

• Urinalysis– Unremarkable in pre and post renal causes– Differentiates ATN vs. AIN. vs. AGN

• Muddy brown casts in ATN

• WBC casts in AIN

– Hansel stain for Eosinophils

Page 10: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Acute Renal FailureDiagnosis (cont’d)

• Urinary Indices;– FE Na = (U/P) Na X (P/U)CrX 100

• FENa < 1% C/W Pre-renal state– May be low in selected intrinsic cause

» Contrast nephropathy

» Acute GN

» Myoglobin induced ATN

• FENa> 1% C/W intrinsic cause of ARF

Page 11: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE
Page 12: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Prerenal Azotemia• Nearly as common as ATN (think of as early

part of the disease spectrum)

• Diagnose by history and physical exam– N/V, Diarrhea, Diuretic use,...

• low FENa (<1%)

• high BUN/creat ratio, normal urinary sediment

• Treat by correction of predisposing factors

Page 13: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE
Page 14: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE
Page 15: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE
Page 16: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Acute Renal Failure Etiologies

• Acute Tubular Necrosis– Most common cause of intrinsic cause of ARF– Often multifactorial– Non-oliguria carries better prognosis– Ischemic ATN:

• Hypotension, sepsis, prolonged pre-renal state

– Nephrotoxic ATN:• Contrast, Antibiotics, Heme proteins

Page 17: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Acute Tubular Necrosis (ATN) -- 2

• Diagnose by history, FENa (>2%)

• sediment with coarse granular casts, RTE cells

• Treatment is supportive care.– Maintenance of euvolemia (with judicious use of diuretics,

IVF, as necessary)– Avoidance of hypotension– Avoidance of nephrotoxic medications (including NSAIDs

and ACE-I) when possible– Dialysis, if necessary

• 80% will recover, if initial insult can be reversed.

Page 18: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE
Page 19: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Contrast nephropathy

• 12-24 hours post exposure, peaks in 3-5 days

• Non-oliguric, FE Na <1% !!

• RX/Prevention: 1/2 NS 1 cc/kg/hr 12 hours pre/post

• Mucomyst 600 BID pre/post (4 doses)

• Risk Factors: CRF, Hypovolemia.

Page 20: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Rhabdomyolytic ARF• Diagnose with serum CPK (usu. > 10,000),

urine dipstick (+) for blood, without RBCs on microscopy, pigmented granular casts

• Common after trauma (“crush injuries”), seizures, burns, limb ischemia occasionally after IABP or cardiopulmonary bypass

• Treatment is largely supportive care.• Alkalinization of urine .

Page 21: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE
Page 22: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Acute Glomerulonephritis• Rare in the hospitalized patient

• Most common types: acute post-infectious GN, “crescentic” RPGN

• Diagnose by history, hematuria, RBC casts, proteinuria (usually non-nephrotic range), low serum complement in post-infectious GN), RPGN often associated with anti-GBM or ANCA

• Usually will need to perform renal biopsy

Page 23: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Acute Glomerulonephritis (2)

• If diagnosis is post-infectious, disease is usually self-limited, and supportive care is usually all that is necessary.

• For RPGN, may need immunosuppressive therapy with steroids ± Cytoxan, plasmapheresis (if assoc. with anti-GBM)

Page 24: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Atheroembolic ARF• Associated with emboli of fragments of atherosclerotic

plaque from aorta and other large arteries• Diagnose by history, physical findings (evidence of

other embolic phenomena--CVA, ischemic digits, “blue toe” syndrome, etc), low serum C3 and C4, peripheral eosinophilia, eosinophiluria, rarely WBC casts

• Commonly occur after intravascular procedures or cannulation (cardiac cath, CABG, AAA repair, etc.)

Page 25: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Acute Interstitial Nephritis – Usually drug induced

• methicillin, rifampin, NSAIDS

– Develops 3-7 days after exposure

– Fever, Rash , and eosinophilia common

– U/A reveals WBC, WBC casts, + Hansel stain

– Often resolves spontaneously

– Steroids may be beneficial ( if Scr>2.5 mg/dl)

Page 26: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Acute Renal Failure Etiologies

• Post-Renal– Bladder outlet obstruction

• BPH, intrapelvic pathology

– Crystalluria• Acyclovir, Indanivir, Uric Acid

– Papillary tip necrosis• DM with pyelonephritis• Analgesic abuse• Sickle cell disease

Page 27: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Prevention

What works?

• Maintenance of euvolemia

• Avoidance of nephrotoxins when possible– NSAIDs, aminoglycoside, Amphotericin, IV

contrast

• BP control--avoidance of excessive hypo- or hypertension

Page 28: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Prevention

What doesn’t work?

• Empiric use of:– Diuretics (i.e., Furosemide, Mannitol)– Dopamine (or Dopamine agonists such as

Fenoldopam)– Calcium-channel blockers

Page 29: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Acute Renal Failure Treatment

• Water and sodium restriction• Protein restriction• Potassium and phosphate restriction• Adjust medication dosages• Avoidance of further insults

– BP support– Nephrotoxins

Page 30: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Hyperkalemia

• Highly Arrhythmogenic– Usually with progressive EKG changes

• Peaked T waves ---> Widened QRS--> Sinus wave

– K> 5.5 meq/L needs evaluation/intervention– Usually in setting of Decrease GFR but:

• medication also a common cause– ACEI

– NSAIDS

– Septra, Heparin

Page 31: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE
Page 32: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE

Dialysis Indications

• Refractory hyperkalemia

• Metabolic acidosis

• Volume overload

• Mental status changes

Page 33: CLINICAL PHARMACY IN NEPHROLOGY ACUTE RENAL FAILURE